- Home
- CAKE vs IBRX Comparison
CAKE vs IBRX Comparison
Compare CAKE & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- IBRX
- Stock Information
- Founded
- CAKE 1972
- IBRX 2014
- Country
- CAKE United States
- IBRX United States
- Employees
- CAKE N/A
- IBRX N/A
- Industry
- CAKE Restaurants
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAKE Consumer Discretionary
- IBRX Health Care
- Exchange
- CAKE Nasdaq
- IBRX Nasdaq
- Market Cap
- CAKE 2.4B
- IBRX 2.4B
- IPO Year
- CAKE 1992
- IBRX N/A
- Fundamental
- Price
- CAKE $55.46
- IBRX $2.75
- Analyst Decision
- CAKE Hold
- IBRX Strong Buy
- Analyst Count
- CAKE 14
- IBRX 5
- Target Price
- CAKE $52.79
- IBRX $11.40
- AVG Volume (30 Days)
- CAKE 1.1M
- IBRX 11.3M
- Earning Date
- CAKE 04-30-2025
- IBRX 05-12-2025
- Dividend Yield
- CAKE 1.96%
- IBRX N/A
- EPS Growth
- CAKE 45.67
- IBRX N/A
- EPS
- CAKE 3.19
- IBRX N/A
- Revenue
- CAKE $3,617,673,000.00
- IBRX $31,222,000.00
- Revenue This Year
- CAKE $7.07
- IBRX $579.01
- Revenue Next Year
- CAKE $6.05
- IBRX $173.61
- P/E Ratio
- CAKE $17.30
- IBRX N/A
- Revenue Growth
- CAKE 4.42
- IBRX 10238.41
- 52 Week Low
- CAKE $33.50
- IBRX $1.83
- 52 Week High
- CAKE $57.32
- IBRX $7.63
- Technical
- Relative Strength Index (RSI)
- CAKE 58.55
- IBRX 55.06
- Support Level
- CAKE $54.43
- IBRX $2.43
- Resistance Level
- CAKE $57.02
- IBRX $2.79
- Average True Range (ATR)
- CAKE 1.40
- IBRX 0.22
- MACD
- CAKE 0.06
- IBRX 0.02
- Stochastic Oscillator
- CAKE 59.45
- IBRX 54.61
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.